0 items USD 0.00Search
- Did you mean
- biosimilar
Your search for "biosimilars" gave back 1017 results.
The global Interchangeable Biosimilar Humira market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by...
Catalog:
GIR
August 2023
Price: USD 3,480.00
The global Avastin Biosimilar market size is projected to grow from US$ 1311.8 million in 2022 to US$ 419.1 million in 2029; it is expected to grow...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Biologics and Biosimilars market size was valued at USD 481830 million in 2022 and is forecast to a readjusted size of USD 843370 million...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Humira Biosimilar market size was valued at USD 433.2 million in 2022 and is forecast to a readjusted size of USD 955.4 million by 2029...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. The global...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Brolucizumab is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). The most...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar...
Catalog:
9Dimen Research
February 2023
Price: USD 3,200.00
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are...
Catalog:
MRRPB5
January 2023
Price: USD 4,000.00
The global Biosimilars Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of %...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Neulasta (Pegfilgrastim) and Biosimilar market size is projected to grow from US$ 2378.1 million in 2022 to US$ 3755 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Adalimumab (Humira) and Biosimilar market size is projected to grow from US$ 21930 million in 2022 to US$ 14950 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Rituxan (Rituximab) and Biosimilar market size is projected to grow from US$ 4035.3 million in 2022 to US$ 5179.6 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Remicade (Infliximab) and Biosimilar market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
